Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Beta-sheet breaker peptide potentially effective against amyloidosis in Alzheimer's disease

July 24, 1998

Genentech stroke study terminated due to inability to demonstrate clinical benefit

July 23, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

Phase III clinical trial results with galantamine suggest novel mechanism of action

July 23, 1998

Nortran initiates phase II trials for local anesthetic

July 23, 1998

New series of neuroprotective compounds described by Nippon Chemiphar

July 23, 1998

Inhaled analgesic available for licensing from BTG

July 23, 1998

Neurogen's epilepsy compound advances through clinical trials

July 22, 1998

Patient dosing begins in phase Ib trial of stroke drug from NPS

July 22, 1998

FDA clears SSRI for depression

July 22, 1998